ACELARIN Uses, Dosage, Side Effects and more
ACELARIN is under investigation in clinical trial NCT03610100 (Acelarin First Line Randomised Pancreatic Study).
| Trade Name | ACELARIN |
| Generic | NUC-1031 |
| NUC-1031 Other Names | ACELARIN, Fosgemcitabine palabenamide, p(rs)- |
| Type | |
| Formula | C25H27F2N4O8P |
| Weight | Average: 580.482 Monoisotopic: 580.153457169 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
